IDXX
IDEXX Laboratories Inc
519.30$
+1.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 54.9% | 55.7% | 55.2% | 56.7% | 42.6% | 37.1% | 46.3% | 39.2% | 40.1% | 45.9% | 42.5% | 40.0% | |
| 23.3% | 8.7% | 10.1% | 11.0% | 8.1% | 4.9% | 16.7% | 5.9% | 4.1% | 13.9% | 8.8% | 5.4% | |
| 23.3% | 23.2% | 25.6% | 27.5% | 8.1% | 4.9% | 16.7% | 5.9% | 4.1% | 13.9% | 8.8% | 5.4% | |
| 13.1% | 13.6% | 15.2% | 15.8% | 16.8% | 16.8% | 16.3% | 17.5% | 17.9% | 16.2% | 14.4% | 20.7% | |
| 11.6% | 12.8% | 10.3% | 9.6% | 11.3% | 10.6% | 9.1% | 11.0% | 13.4% | 11.7% | 11.6% | 11.3% | |
| 21.9% | 22.6% | 23.4% | 22.1% | 28.4% | 29.1% | 24.2% | 24.1% | 23.6% | – | – | – | |
| 13.3% | 12.1% | 11.6% | 11.7% | 14.0% | 13.1% | 10.6% | 14.7% | 13.2% | 11.2% | 12.3% | 12.4% | |
| 4.7% | 3.8% | 3.0% | 2.6% | 2.7% | 3.2% | 2.3% | 4.1% | 3.6% | 2.6% | 3.4% | 3.3% | |
| 91.5% | 105.7% | 107.1% | 103.1% | 100.6% | 90.3% | 72.4% | 71.7% | 77.8% | 54.5% | 51.6% | 52.1% | |
| 59.3% | 58.1% | 61.1% | 58.6% | 50.1% | 39.6% | 25.4% | 31.3% | 45.0% | 29.2% | 32.4% | 34.3% | |
| 39.7% | 38.8% | 39.9% | 38.2% | 25.9% | 16.6% | 3.0% | 6.9% | 24.6% | 10.6% | 5.1% | 14.9% | |
| 3.2% | 3.6% | 3.9% | 3.9% | 4.5% | 3.9% | 3.2% | 4.8% | 4.0% | 3.4% | 3.5% | 3.3% | |
| 25.3% | 40.5% | 38.7% | 35.4% | 39.1% | 38.1% | 37.4% | 31.8% | 25.3% | 19.1% | 13.7% | 11.2% | |
| 8.5% | -5.7% | -7.1% | -3.2% | -0.6% | 9.7% | 27.5% | 28.3% | 22.2% | 45.5% | 48.4% | 47.9% | |
| 121.0% | 21.6% | 35.3% | 46.9% | 76.0% | 87.1% | 94.8% | 119.8% | 131.0% | 136.3% | 161.9% | 190.8% | |
| 7.3% | 6.3% | 5.9% | 5.2% | 5.8% | 4.8% | 3.8% | 3.6% | 3.1% | 2.6% | 2.5% | 2.4% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.